Amarilys Silva-Boschetti – Executive Director & Director of Operations & Miguel Vazquez-Padua – Business Development, Puerto Rico Consortium for Clinical Investigation (PRCCI)

Dr Amarilys Silva-Boschetti and Dr Miguel Vázquez-Padua of the Puerto Rico Consortium for Clinical Investigation (PRCCI) underline the various benefits for pharmaceutical, biotechnology and medtech companies to conduct clinical trials in Puerto Rico. They also highlight further steps of how the Consortium, which is part of the Puerto Rico Science, Technology & Research Trust, will aim to transform the island into a global hub for clinical research and investigation.  
Puerto Rico has been involved in clinical research since the 1960s, and there have been many success stories over that time
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Already a member? Sign In

Related Interviews

Latest Report